Please login to the form below

secukinumab

This page shows the latest secukinumab news and features for those working in and with pharma, biotech and healthcare.

GSK sells eczema and psoriasis drug to Dermavant for £250m

In the case of psoriasis, that includes not only new therapies such as Novartis’IL-17 inhibitor Cosentyx (secukinumab) and Johnson &Johnson’s IL-23/IL-12 inhibitor Tremfya (guselkumab), but

Latest news

UK, Germany back routine use of J&J’s Tremfya

psoriasis therapies such as Novartis’fast-growing IL-17 inhibitor Cosentyx (secukinumab), which EvaluatePharma expects to become a $4.6bn product by 2022.
Sun Pharma passes milestone with novel psoriasis drug approval

IL-23-selective follow-up Tremfya (guselkumab) as well as three IL-17 inhibitors - Novartis’ Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) and Valeant Pharma’s Siliq (brodalumab).
AbbVie reports more solid data for would-be psoriasis blockbuster

Its profile could also help it make headway against other new psoriasis drugs, including IL-17 inhibitors such as Novartis’fast-growing Cosentyx (secukinumab) as well as Eli Lilly’s Taltz
Novartis negotiates ex-US rights to Spark gene therapy

The gains were driven by strong performances from new immunotherapy Cosentyx (secukinumab), which breached the $2bn sales threshold for the year, as well as heart failure therapy Entresto (sacubitril and valsartan)
Lilly claims another EU okay for Taltz

up in the market with Novartis’first-to-market IL-17 inhibitor Cosentyx (secukinumab) which was approved for psoriasis several months earlier and has since had its uses extended to include

More from news
Approximately 16 fully matching, plus 58 partially matching documents found.

Latest appointments

AIMM Therapeutics appoints former Novartis VP Jan de Vries as CEO

multiple sclerosis and secukinumab for several inflammatory conditions.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Senior Project Manager - Medical Writing: Great salary and bebefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Home based, Principal Medical Writer, Medical Communications: Excellent package

Delivery Manager/ Head of Delivery – Executive Search: Neg

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Home based, Editorial Team Leader, Medical Communications: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Senior Account Manager: Competitive salary commensurate with experience

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Business Unit Head, Medical Communications, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Client Services Director – Healthcare Advertising - London: Neg

Account Manager: £40, 000 - £45, 000 benefits

Subscribe to our email news alerts

PMHub

Add my company

Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....